20-hydroxy-5,8,11,14-eicosatetraenoic acid and ubiquinone

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with ubiquinone in 1 studies

Compound Research Comparison

Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid)	Studies (ubiquinone)	Trials (ubiquinone)	Recent Studies (post-2010) (ubiquinone)
640	13	233	9,497	597	3,655

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chew, GT; Hamilton, SJ; Watts, GF	1

Trials

1 trial(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and ubiquinone

Article	Year
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes care, 2009, Volume: 32, Issue:5 Topics: Adult; Aged; Blood Flow Velocity; Blood Pressure; Brachial Artery; Cholesterol, LDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Oxidative Stress; Placebos; Ubiquinone; Vasodilation	2009

Article

Year

Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.

Diabetes care, 2009, Volume: 32, Issue:5

Topics: Adult; Aged; Blood Flow Velocity; Blood Pressure; Brachial Artery; Cholesterol, LDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Oxidative Stress; Placebos; Ubiquinone; Vasodilation

2009